You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Low-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reactions to infliximab.
- In: Hospital Pharmacy Section - Poster Session
- At: Salvadore (Brazil) (2006)
- Type: Poster
- Poster code: HPS-P-023
- By: AUGUSTSSON, Jenny (Apoteket AB, Stockholm, Sweden)
- Co-author(s): Ernestam, Sofia (Karolinska Institute, STOCKHOLM, Sweden)
Eksborg, Staffan (Karolinska Institute, STOCKHOLM, Sweden)
Van Vollenhoven, Ronald (Karolinska Institute, STOCKHOLM, Sweden) - Abstract:
Background:
Infusion reactions are a well-described complication of infliximab (Remicade) therapy and represent the cause of appr. 15% of the discontinuations of this treatment. The aim of this study was to investigate the role of glucocorticoids and possible predictors of infusion reactions, thus improving the patient safety.
Methods:
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026